Dar Al Dawa Development and Investment Co. Ltd. (ASE:DADI)

Market Cap	41.65M -4.8%
Revenue (ttm)	79.99M +4.5%
Net Income	4.07M +21.5%
EPS	0.12 +21.5%
Shares Out	35.00M
PE Ratio	10.23
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	176,130
Average Volume	307,010
Open	1.180
Previous Close	1.180
Day's Range	1.180 - 1.190
52-Week Range	1.090 - 1.310
Beta	0.27
RSI	52.11
Earnings Date	Feb 11, 2026

About ASE:DADI

Dar Al Dawa Development and Investment Co. Ltd., an integrated pharmaceutical company, develops, manufactures, markets, and distributes pharmaceutical and consumer healthcare products in Levant, Gulf and Yemen, the Middle East, Africa, Europe, and Asia. The company offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, urology, respiratory, gastrointestinal, analgesic and musculoskeletal, central nervous system, gynecology, dermatology, ophthalmology, and oncology; and cereal and milk formula products for infan...

• Industry: Pharmaceutical Preparations
• Founded: 1975
• Employees: 1,111
• Stock Exchange: Amman Stock Exchange
• Ticker Symbol: DADI

Financial Performance

In 2024, ASE:DADI's revenue was 81.18 million, an increase of 8.42% compared to the previous year's 74.88 million. Earnings were 3.59 million, an increase of 13.41%.